Activatable nanoprobes for biomolecular detection

Current Opinion in Biotechnology

Volumn 34, Issue , 2015, Pages 171-179

  Zhang, Pengcheng ^a   Cheetham, Andrew G ^a   Lock, Lye Lin ^a   Li, Yaping ^b   Cui, Honggang ^a,c  

^a Johns Hopkins University   (United States)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; DIAGNOSIS; NANOPROBES;

BIOMOLECULAR DETECTIONS; BIOMOLECULE DETECTION; DETECTION OF BIOMOLECULES; DISEASE DIAGNOSIS; IN-VITRO; NANO-SCALE OBJECTS; SUB-CELLULAR;

OBJECT DETECTION;

INORGANIC NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG; INORGANIC COMPOUND; NANOMATERIAL;

ACTIVABLE NANOPROBE; CONFORMATION; DATA ANALYSIS; EQUIPMENT DESIGN; EXPERIMENTAL DESIGN; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; IMAGE ANALYSIS; MOLECULAR DYNAMICS; MOLECULAR IMAGING; MOLECULAR INTERACTION; NANOPROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRODUCT DEVELOPMENT; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY ANALYSIS; ANIMAL; CHEMISTRY; MEDICAL RESEARCH;

ANIMALS; BIOMEDICAL RESEARCH; HUMANS; INORGANIC CHEMICALS; NANOSTRUCTURES;

EID: 84922606092     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2015.01.009     Document Type: Review

References (60)

1. Weinberg R.A. The Biology of Cancer 2007, Garland Science.
2. Clayton T.A., Lindon J.C., Cloarec O., Antti H., Charuel C., Hanton G., Provost J.P., Le Net J.L., Baker D., Walley R.J., et al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 2006, 440:1073-1077.
3. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422:198-207.
4. Yu M.K., Park J., Jon S. Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2012, 2:3-44.
5. Choi H.S., Liu W.H., Liu F.B., Nasr K., Misra P., Bawendi M.G., Frangioni J.V. Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol 2010, 5:42-47.
6. Weissleder R., Pittet M.J. Imaging in the era of molecular oncology. Nature 2008, 452:580-589.
7. Willmann J.K., van Bruggen N., Dinkelborg L.M., Gambhir S.S. Molecular imaging in drug development. Nat Rev Drug Discov 2008, 7:591-607.
8. Hussain T., Nguyen Q.T. Molecular imaging for cancer diagnosis and surgery. Adv Drug Deliver Rev 2014, 66:90-100.
9. van Dam G.M., Themelis G., Crane L.M.A., Harlaar N.J., Pleijhuis R.G., Kelder W., Sarantopoulos A., de Jong J.S., Arts H.J.G., van der Zee A.G.J., et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med 2011, 17. 1315-1319.
10. Kairdolf B.A., Smith A.M., Stokes T.H., Wang M.D., Young A.N., Nie S.M. Semiconductor quantum dots for bioimaging and biodiagnostic applications. Annu Rev Anal Chem 2013, 6:143-162.
11. Hoeks C.M.A., Barentsz J.O., Hambrock T., Yakar D., Somford D.M., Heijmink S.W.T.P.J., Scheenen T.W.J., Vos P.C., Huisman H., van Oort I.M., et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 2011, 261:46-66.
12. Janib S.M., Moses A.S., MacKay J.A. Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliver Rev 2010, 62:1052-1063.
13. Choi K.Y., Liu G., Lee S., Chen X.Y. Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. Nanoscale 2012, 4:330-342.
14. Lammers T., Aime S., Hennink W.E., Storm G., Kiessling F. Theranostic nanomedicine. Accounts Chem Res 2011, 44:1029-1038.
15. Brindle K. New approaches for imaging tumour responses to treatment. Nat Rev Cancer 2008, 8:94-107.
16. Jares-Erijman E.A., Jovin T.M. FRET imaging. Nat Biotechnol 2003, 21:1387-1395.
17. Zhou K.J., Liu H.M., Zhang S.R., Huang X.N., Wang Y.G., Huang G., Sumer B.D., Gao J.M. Multicolored pH-tunable and activatable fluorescence nanoplatform responsive to physiologic pH stimuli. J Am Chem Soc 2012, 134:7803-7811.
18. Tu C.Q., Osborne E.A., Louie A.Y. Activatable T (1) and T (2) magnetic resonance imaging contrast agents. Ann Biomed Eng 2011, 39:1335-1348.
19. Zhang H., Pan J., Hogen-Esch T.E. Synthesis and characterization of one-ended perfluorocarbon-functionalized derivatives of poly(ethylene glycol)s. Macromolecules 1998, 31:2815-2821.
20. Nie S.M., Xing Y., Kim G.J., Simons J.W. Nanotechnology applications in cancer. Annu Rev Biomed Eng 2007, 9:257-288.
21. Howes P.D., Chandrawati R., Stevens M.M. Colloidal nanoparticles as advanced biological sensors. Science 2014, 346:1247390.
22. Ren C., Zhang J., Chen M., Yang Z. Self-assembling small molecules for the detection of important analytes. Chem Soc Rev 2014, 43:7257-7266.
23. Peer D., Karp J.M., Hong S., FaroKHzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
24. Hilderbrand S.A., Weissleder R. Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol 2010, 14:71-79.
25. Kobayashi H., Longmire M.R., Ogawa M., Choyke P.L. Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals. Chem Soc Rev 2011, 40:4626-4648.
26. Lee S., Xie J., Chen X.Y. Activatable molecular probes for cancer imaging. Curr Top Med Chem 2010, 10:1135-1144.
27. Pysz M.A., Gambhir S.S., Willmann J.K. Molecular imaging: current status and emerging strategies. Clin Radiol 2010, 65:500-516.
28. Razgulin A., Ma N., Rao J. Strategies for in vivo imaging of enzyme activity: an overview and recent advances. Chem Soc Rev 2011, 40(7):4186-4216. PMID: 21552609.
29. Yun C.S., Javier A., Jennings T., Fisher M., Hira S., Peterson S., Hopkins B., Reich N.O., Strouse G.F. Nanometal surface energy transfer in optical rulers, breaking the FRET barrier. J Am Chem Soc 2005, 127:3115-3119.
30. Mu C.J., Lavan D.A., Langer R.S., Zetter B.R. Self-assembled gold nanoparticle molecular probes for detecting proteolytic activity in vivo. Acs Nano 2010, 4:1511-1520.
31. Qian R.C., Ding L., Yan L.W., Lin M.F., Ju H.X. A robust probe for lighting up intracellular telomerase via primer extension to open a nicked molecular beacon. J Am Chem Soc 2014, 136:8205-8208.
32. Lee H., Lee K., Kim I.K., Park T.G. Fluorescent gold nanoprobe sensitive to intracellular reactive oxygen species. Adv Funct Mater 2009, 19:1884-1890.
33. Thorek D.L.J., Ogirala A., Beattie B.J., Grimm J. Quantitative imaging of disease signatures through radioactive decay signal conversion. Nat Med 2013, 19:1345-1350.
34. Prigodich A.E., Randeria P.S., Briley W.E., Kim N.J., Daniel W.L., Giljohann D.A., Mirkin C.A. Multiplexed nanoflares: mRNA detection in live cells. Anal Chem 2012, 84:2062-2066.
35. Pan W., Zhang T.T., Yang H.J., Diao W., Li N., Tang B. Multiplexed detection and imaging of intracellular mRNAs using a four-color nanoprobe. Anal Chem 2013, 85:10581-10588.
36. Yang K., Zhu L., Nie L.M., Sun X.L., Cheng L., Wu C.X., Niu G., Chen X.Y., Liu Z. Visualization of protease activity in vivo using an activatable photo-acoustic imaging probe based on CuS nanoparticles. Theranostics 2014, 4:134-141.
37. Rodriguez-Lorenzo L., de la Rica R., Alvarez-Puebla R.A., Liz-Marzan L.M., Stevens M.M. Plasmonic nanosensors with inverse sensitivity by means of enzyme-guided crystal growth. Nat Mater 2012, 11:604-607.
38. Chen T., Wu C.S., Jimenez E., Zhu Z., Dajac J.G., You M.X., Han D., Zhang X.B., Tan W.H. DNA micelle flares for intracellular mRNA imaging and gene therapy. Angew Chem Int Ed 2013, 52:2012-2016.
39. Lock L.L., Cheetham A.G., Zhang P.C., Cui H.G. Design and construction of supramolecular nanobeacons for enzyme detection. Acs Nano 2013, 7:4924-4932.
40. Ma X.P., Wang Y.G., Zhao T., Li Y., Su L.C., Wang Z.H., Huang G., Sumer B.D., Gao J.M. Ultra-pH-sensitive nanoprobe library with broad pH tunability and fluorescence emissions. J Am Chem Soc 2014, 136:11085-11092.
41. Lin X., Xie J., Zhu L., Lee S., Niu G., Ma Y., Kim K., Chen X.Y. Hybrid ferritin nanoparticles as activatable probes for tumor imaging. Angew Chem Int Ed 2011, 50:1569-1572.
42. Mok H., Jeong H., Kim S.J., Chung B.H. Indocyanine green encapsulated nanogels for hyaluronidase activatable and selective near infrared imaging of tumors and lymph nodes. Chem Commun (Camb) 2012, 48:8628-8630.
43. Wang Y.G., Zhou K.J., Huang G., Hensley C., Huang X.N., Ma X.P., Zhao T., Sumer B.D., DeBerardinis R.J., Gao J.M. A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals. Nat Mater 2014, 13:204-212.
44. Lovell J.F., Jin C.S., Huynh E., Jin H.L., Kim C., Rubinstein J.L., Chan W.C.W., Cao W.G., Wang L.V., Zheng G. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater 2011, 10:324-332.
45. Gao Y., Shi J.F., Yuan D., Xu B. Imaging enzyme-triggered self-assembly of small molecules inside live cells. Nat Commun 2012, 3:1033.
46. Chen J.W., Pham W., Weissleder R., Bogdanov A. Human myeloperoxidase: a potential target for molecular MR imaging in atherosclerosis. Magn Resonance Med/Soc Magn Resonance Med 2004, 52:1021-1028.
47. Kim T., Cho E.J., Chae Y., Kim M., Oh A., Jin J., Lee E.S., Baik H., Haam S., Suh J.S., et al. Urchin-shaped manganese oxide nanoparticles as pH-responsive activatable T-1 contrast agents for magnetic resonance imaging. Angew Chem Int Ed 2011, 50:10589-10593.
48. 19F nuclear magnetic resonance signals for protein detection and imaging. Nat Chem 2009, 1:557-561.
49. 19F MRI probes. Chem-Eur J 2013, 19:12875-12883.
50. 19F-MRI nanoprobes with binary ON/OFF pH transitions and chemical-shift barcodes. Angew Chem Int Ed 2013, 52:8074-8078.
51. Kastantin M., Missirlis D., Black M., Ananthanarayanan B., Peters D., Tirrell M. Thermodynamic and kinetic stability of DSPE-PEG(2000) micelles in the presence of bovine serum albumin. J Phys Chem B 2010, 114:12632-12640.
52. Kim E., Yang J., Park J., Kim S., Kim N.H., Yook J.I., Suh J.S., Haam S., Huh Y.M. Consecutive targetable smart nanoprobe for molecular recognition of cytoplasmic microRNA in metastatic breast cancer. Acs Nano 2012, 6:8525-8535.
53. Zhu L., Huang X., Choi K.Y., Ma Y., Zhang F., Liu G., Lee S., Chen X. Real-time monitoring of caspase cascade activation in living cells. J Control Release 2012, 163:55-62.
54. Olson E.S., Aguilera T.A., Jiang T., Ellies L.G., Nguyen Q.T., Wong E.H., Gross L.A., Tsien R.Y. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr Biol 2009, 1:382-393.
55. Nguyen Q.T., Olson E.S., Aguilera T.A., Jiang T., Scadeng M., Ellies L.G., Tsien R.Y. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci USA 2010, 107:4317-4322.
56. Olson E.S., Jiang T., Aguilera T.A., Nguyen Q.T., Ellies L.G., Scadeng M., Tsien R.Y. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci USA 2010, 107:4311-4316.
57. Viger M.L., Sankaranarayanan J., Lux C.D., Chan M., Almutairi A. Collective activation of MRI agents via encapsulation and disease-triggered release. J Am Chem Soc 2013, 135:7847-7850.
58. Lee D., Khaja S., Velasquez-Castano J.C., Dasari M., Sun C., Petros J., Taylor W.R., Murthy N. In vivo imaging of hydrogen peroxide with chemiluminescent nanoparticles. Nat Mater 2007, 6:765-769.
59. Lim C.K., Lee Y.D., Na J., Oh J.M., Her S., Kim K., Choi K., Kim S., Kwon I.C. Chemiluminescence-generating nanoreactor formulation for near-infrared imaging of hydrogen peroxide and glucose level in vivo. Adv Funct Mater 2010, 20:2644-2648.
60. Lee D., Bae S., Ke Q.E., Lee J., Song B., Karumanchi S.A., Khang G., Choi H.S., Kang P.M. Hydrogen peroxide-responsive copolyoxalate nanoparticles for detection and therapy of ischemia-reperfusion injury. J Control Release 2013, 172:1102-1110.